J. Pedro-Botet Montoya

[Atherogenic dyslipidemia and residual risk. State of the art in 2014].

J. Millán Núñez-Cortés, X. Pintó Sala, J. Pedro-Botet Montoya, 2014, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.

[Bacteremia of cutaneous origin].

J. Rubiés-prat, J. Pedro-Botet Montoya, L. Drobnic, 1990, Anales de medicina interna.

Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study

J. Millán Núñez-Cortés, X. Pintó Sala, A. Cases Amenós, 2016, American Journal of Cardiovascular Drugs.

Delphi consensus on the diagnosis and management of dyslipidaemia in chronic kidney disease patients: A post hoc analysis of the DIANA study.

J. Millán Núñez-Cortés, X. Pintó Sala, A. Cases Amenós, 2016, Nefrología.

[To improve cardiovascular health: we are forced for not loosing impulse].

J. Millán Núñez-Cortés, J. M. Lobos Bejarano, T. Mantilla Morató, 2016, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.

[Bezafibrate-induced necrotizing myopathy].

J. Fueyo, J. Fernandez-Solà, J. Pedro-Botet Montoya, 1991, Medicina clinica.